Cargando…

Optimizing Workflows for Fast and Reliable Metabolic Tumor Volume Measurements in Diffuse Large B Cell Lymphoma

PURPOSE: This pilot study aimed to determine interobserver reliability and ease of use of three workflows for measuring metabolic tumor volume (MTV) and total lesion glycolysis (TLG) in diffuse large B cell lymphoma (DLBCL). PROCEDURES: Twelve baseline [(18)F]FDG PET/CT scans from DLBCL patients wit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Burggraaff, Coreline N., Rahman, Fareen, Kaßner, Isabelle, Pieplenbosch, Simone, Barrington, Sally F., Jauw, Yvonne W.S., Zwezerijnen, Gerben J.C., Müller, Stefan, Hoekstra, Otto S., Zijlstra, Josée M., De Vet, Henrica C.W., Boellaard, Ronald
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7343740/ https://www.ncbi.nlm.nih.gov/pubmed/31993925 http://dx.doi.org/10.1007/s11307-020-01474-z

Ejemplares similares

Reproducibility of [18F]FDG PET/CT liver SUV as reference or normalisation factor
por: Zwezerijnen, Gerben J. C., et al.
Publicado: (2022)

Quantitative implications of the updated EARL 2019 PET–CT performance standards
por: Kaalep, Andres, et al.
Publicado: (2019)

PET segmentation of bulky tumors: Strategies and workflows to improve inter-observer variability
por: Pfaehler, Elisabeth, et al.
Publicado: (2020)

Proposed New Dynamic Prognostic Index for Diffuse Large B-Cell Lymphoma: International Metabolic Prognostic Index
por: Mikhaeel, N. George, et al.
Publicado: (2022)

Baseline radiomics features and MYC rearrangement status predict progression in aggressive B-cell lymphoma
por: Eertink, Jakoba J., et al.
Publicado: (2022)

External validation: a simulation study to compare cross-validation versus holdout or external testing to assess the performance of clinical prediction models using PET data from DLBCL patients
por: Eertink, Jakoba J., et al.
Publicado: (2022)

Predictive value of interim positron emission tomography in diffuse large B-cell lymphoma: a systematic review and meta-analysis
por: Burggraaff, Coreline N., et al.
Publicado: (2018)

Interobserver reproducibility of tumor uptake quantification with (89)Zr-immuno-PET: a multicenter analysis
por: Jauw, Yvonne W. S., et al.
Publicado: (2019)

Comparing lesion and feature selections to predict progression in newly diagnosed DLBCL patients with FDG PET/CT radiomics features
por: Eertink, Jakoba J., et al.
Publicado: (2022)

Combatting the effect of image reconstruction settings on lymphoma [(18)F]FDG PET metabolic tumor volume assessment using various segmentation methods
por: Ferrández, Maria C., et al.
Publicado: (2022)

(18)F-FDG PET baseline radiomics features improve the prediction of treatment outcome in diffuse large B-cell lymphoma
por: Eertink, Jakoba J., et al.
Publicado: (2021)

An artificial intelligence method using FDG PET to predict treatment outcome in diffuse large B cell lymphoma patients
por: Ferrández, Maria C., et al.
Publicado: (2023)

Updating PET/CT performance standards and PET/CT interpretation criteria should go hand in hand
por: Boellaard, Ronald, et al.
Publicado: (2019)

3D Convolutional Neural Network-Based Denoising of Low-Count Whole-Body (18)F-Fluorodeoxyglucose and (89)Zr-Rituximab PET Scans
por: de Vries, Bart M., et al.
Publicado: (2022)

Noise-Induced Variability of Immuno-PET with Zirconium-89-Labeled Antibodies: an Analysis Based on Count-Reduced Clinical Images
por: Jauw, Yvonne W. S., et al.
Publicado: (2018)

Sensitivity of an AI method for [(18)F]FDG PET/CT outcome prediction of diffuse large B-cell lymphoma patients to image reconstruction protocols
por: Ferrández, Maria C., et al.
Publicado: (2023)

Potential and pitfalls of (89)Zr-immuno-PET to assess target status: (89)Zr-trastuzumab as an example
por: Huisman, Marc C., et al.
Publicado: (2021)

Baseline PET radiomics outperforms the IPI risk score for prediction of outcome in diffuse large B-cell lymphoma
por: Eertink, J. J., et al.
Publicado: (2023)

Impact of partial-volume correction in oncological PET studies: a systematic review and meta-analysis
por: Cysouw, Matthijs C. F., et al.
Publicado: (2017)

Blood‐circulating EV‐miRNAs, serum TARC, and quantitative FDG‐PET features in classical Hodgkin lymphoma
por: Drees, Esther E. E., et al.
Publicado: (2022)

Performance of (89)Zr-Labeled-Rituximab-PET as an Imaging Biomarker to Assess CD20 Targeting: A Pilot Study in Patients with Relapsed/Refractory Diffuse Large B Cell Lymphoma
por: Jauw, Yvonne W. S., et al.
Publicado: (2017)

Prognostic model using (18)F-FDG PET radiomics predicts progression-free survival in relapsed/refractory Hodgkin lymphoma
por: Driessen, Julia, et al.
Publicado: (2023)

Aberrant patterns of PET response during treatment for DLBCL patients with MYC gene rearrangements
por: Eertink, J. J., et al.
Publicado: (2021)

Immuno-Positron Emission Tomography with Zirconium-89-Labeled Monoclonal Antibodies in Oncology: What Can We Learn from Initial Clinical Trials?
por: Jauw, Yvonne W. S., et al.
Publicado: (2016)

Convolutional neural networks for automatic image quality control and EARL compliance of PET images
por: Pfaehler, Elisabeth, et al.
Publicado: (2022)

Noise sensitivity of (89)Zr-Immuno-PET radiomics based on count-reduced clinical images
por: Somasundaram, Ananthi, et al.
Publicado: (2022)

Progression and Regression: Distinct Developmental Patterns of Diabetic Retinopathy in Patients With Type 2 Diabetes Treated in the Diabetes Care System West-Friesland, the Netherlands
por: Zavrelova, Hata, et al.
Publicado: (2011)

Effects of Tracer Uptake Time in Non–Small Cell Lung Cancer (18)F-FDG PET Radiomics
por: Kolinger, Guilherme D., et al.
Publicado: (2022)

The influence of study population and definition of improvement on the smallest detectable change and the minimal important change of the neck disability index
por: Schuller, Wouter, et al.
Publicado: (2014)

Understanding Ferguson's δ: time to say good-bye?
por: Terluin, Berend, et al.
Publicado: (2009)

Optimal imaging time points considering accuracy and precision of Patlak linearization for (89)Zr-immuno-PET: a simulation study
por: Wijngaarden, Jessica E., et al.
Publicado: (2022)

Variable selection under multiple imputation using the bootstrap in a prognostic study
por: Heymans, Martijn W, et al.
Publicado: (2007)

Predictive value of quantitative (18)F-FDG-PET radiomics analysis in patients with head and neck squamous cell carcinoma
por: Martens, Roland M., et al.
Publicado: (2020)

Analysis of the construct of dignity and content validity of the patient dignity inventory
por: Albers, Gwenda, et al.
Publicado: (2011)

Reproducibility of the STARD checklist: an instrument to assess the quality of reporting of diagnostic accuracy studies
por: Smidt, Nynke, et al.
Publicado: (2006)

Clinically feasible semi-automatic workflows for measuring metabolically active tumour volume in metastatic melanoma
por: van Sluis, Joyce, et al.
Publicado: (2020)

Important outcomes of moral case deliberation: a Euro-MCD field survey of healthcare professionals’ priorities
por: Svantesson, Mia, et al.
Publicado: (2019)

Characterizing the Bone Marrow Environment in Advanced-Stage Myelofibrosis during Ruxolitinib Treatment Using PET/CT and MRI: A Pilot Study
por: Slot, Stefanie, et al.
Publicado: (2023)

Prediction of persistent shoulder pain in general practice: Comparing clinical consensus from a Delphi procedure with a statistical scoring system
por: Vergouw, David, et al.
Publicado: (2011)

Defining the optimal method for measuring baseline metabolic tumour volume in diffuse large B cell lymphoma
por: Ilyas, Hajira, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_uapbohhl39hvl8hop5jddqotum